AssureRx (Mason), Juventas Therapeutics (Cleveland), and ImageIQ (Cleveland) are featured in recent issues of widely read biomedical trade publications.

Personalized medicine company AssureRx receives a favorable nod in a Genetic Engineering & Biotechnology News article titled “Moving Quickly from an Idea to a Product.” Author Brad Webb says AssureRx is “emblematic of this new wave of smart, personal medicine.”

The current GEN issue also includes an article on progress in the regenerative medicine field. Juventas Therapeutics CEO Rahul Aras, PhD, discusses his company’s lead product, Stromal–cell Derived Factor 1 (SDF–1).

Medical Device Daily covers imaging contract research organization ImageIQ’s recently signed agreement with NASA. Reporter Omar Ford offers nice backround on the company too.